Novyy vzglyad na biologicheskie osobennosti pervichnoy ekstranodal'noy diffuznoy V-krupnokletochnoy limfomy
- 作者: Subortseva IN1, Kovrigina AM1, Korobko IV1, Poddubnaya IV1
-
隶属关系:
- 期: 卷 14, 编号 3 (2012)
- 页面: 50-56
- 栏目: Articles
- ##submission.dateSubmitted##: 09.04.2020
- ##submission.datePublished##: 15.09.2012
- URL: https://modernonco.orscience.ru/1815-1434/article/view/29508
- ID: 29508
如何引用文章
全文:
详细
参考
- Поддубная И.В. Неходжкинские лимфомы. Клиническая онкогематология. Под ред. М.А.Волковой. М.: Медицина. 2007; 35: 724-70.
- Бабичева Л.Г. Значение прогностических факторов при лечении больных диффузной крупноклеточной В-клеточной лимфомой антрациклинсодержащими режимами химиотерапии. Автореф. дис. ... канд. мед. наук. 2005.
- Сотникова О.П. Редкие формы экстранодальных неходжкинских лимфом. Автореф. дис. ... канд. мед. наук. 2012.
- Zucca E, Cavalli F. Extranodal lymphomas. Ann Oncol 2000; 11 (Suppl. 3): 219-22.
- Zucca E, Roggero E, Bertoni F et al. Primary extranodal non-Hodgkin's lymphomas, part 1. Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8: 727-37.
- Zucca E, Roggero E, Bertoni F et al. Primary extranodal non-Hodgkin's lymphomas, part 2: Head and neck, central nervous system and other less common sites. Ann Oncol 1999; 10: 1023-33.
- Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1992; 29: 252-60.
- Otter R, Gerrits W, Sandt M et al. Primary extranodal and nodal non-Hodgkin's lymphoma: A survey of a population-based registry. Eur J Cancer Clin Oncol 1989; 25: 1203-10.
- Rudders RA, Ross ME, DeLellis RA. Primary extranodal lymphoma: Response to treatment and factors influencing prognosis. Cancer 1978; 42: 406-16.
- Talaulikar D, Shadbolt B, Dahlstrom JE et al. Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI). J Hematol Oncol 2009; 22: 2-49.
- Sehn LH, Berry B, Chhanabhai M et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 2007; 109 (5): 1857-61.
- Advani RH, Chen H, Habermann TM et al. Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI). Br J Haematol 2010; 151 (2): 143-51.
- Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. WHO Classification of Tumors: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France, IARC Press 2001; p. 171-4.
- Pileri SA, Dirnhofer S, Went Ph et al. Diffuse large B-cell lymphoma: One or more entities? Present controversies and possible tools for its subclassification. Histopathology 2002; 41: 482-509.
- Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275-82.
- Ковригина А.М. Морфоиммуногистохимическая диагностика как основа диагноза лимфомы. Вместе против рака. Врачам всех специальностей. М., 2006; 2.
- Friedberg JW, Fisher RI. Diffuse large B-cell lymphoma. Hematol Oncol Clin North Am 2008; 22 (5): 941-52.
- Colomo L, López-Guillermo A, Perales M et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Am J Surg Pathol 2004; 28: 736-47.
- Muris JJ, Ylstra B, Cillessen SA et al. Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas. Br J Haematol 2007; 136 (1): 38-47.
- Choi WW, Weisenburger DD, Greiner TC et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 2009; 15 (17): 5494-502.
- Lossos IS, Morgensztern D. Prognostic biomarkers in diffuse large B-cell lymphoma. J Clin Oncol 2006; 24 (6): 995-1007.
- Rosenwald A, Wrights G, Chan WC et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937-47.
- Visco C, Li Y, Xu-Monette ZY et al. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 2012; p. 1-11; doi: 10.1038/leu.2012.83.
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
- Вихрева П.Н., Шепелев М.В., Коробко Е.В., Коробко И.В. Свойства и функции супрессора опухолевого роста Pdcd4 и возможности их использования в онкологии. Мол. генет. микробиол. вирусол. 2010; 2: 3-11.
- Hilliard А, Hilliard B, Zheng SJ et al. Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death. J Immunol 2006; 177 (11): 8095-102.
- Carayol N, Katsoulidis E, Sassano A et al. Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway. J Biol Chem 2008; 283 (13): 8601-10.
- Miller TP, Grogan TM, Dahlberg S et al. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: A prospective Southwest Oncology Group trial. Blood 1994; 83: 1460-6.
- Lossos IS, Morgensztern D. Prognostic biomarkers in diffuse large B-cell lymphoma. J Clin Oncol 2006; 24 (6): 995-1007.
- Jerkeman M, Anderson H, Dictor M et al. Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma - a Nordic Lymphoma Group study. Ann Hematol 2004; 83 (7): 414-9.
- Hoeller S, Schneider A, Haralambieva E. FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1. Histopathology 2010; 57 (1): 73-80.